• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Feb. 4

    MO SCI Acquires Assets of 3M’s Advanced Materials Business

    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Paragon Medical

    Medbio LLC

    JBC Technologies

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Paragon Medical

    Medbio LLC

    JBC Technologies

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Warns Genomics Lab About Illegally Marketing Genetic Test

    Inova Genomics Laboratory's test claims to predict patients’ responses to specific medications based on genetic variants.

    Related Content
    • Bright Future Ahead for Renal Denervation
    • FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients
    • Baxter Begins Collaboration with Amazon Web Services
    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    • BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    U.S. Food and Drug Administration04.05.19
    the U.S. Food and Drug Administration issued a warning letter to Inova Genomics Laboratory (Inova) of Falls Church, Va., for illegally marketing certain genetic tests that have not been reviewed by the FDA for safety and effectiveness. The tests claim to predict patients’ responses to specific medications based on genetic variants. Selecting or changing drug treatment in response to the test results could lead to potentially serious health consequences for patients. The FDA is unaware of any data establishing that Inova’s tests can help patients or health care providers make appropriate treatment decisions for the listed drugs. The action reflects the agency’s commitment to monitor the pharmacogenetic test landscape and take action when appropriate to address a significant public health risk.
     
    “Consumers are increasingly embracing genetic testing to better understand their individual risk for developing diseases. With this rise in popularity and availability, we’re also seeing significant activity in the field of pharmacogenetics, which is the process of understanding what, if any, role genetics plays in a patient’s reaction to particular drugs. Without appropriate evaluation to determine whether these tests work, patients are being put at risk—potentially impacting treatment decisions by providing false promise that they will respond well to a certain medicine or keeping them from using therapies that may benefit them,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “We are issuing this warning letter as part of our ongoing efforts to protect the public from the significant risk these tests pose. We are particularly concerned about pharmacogenetic tests that claim to predict patients’ responses to specific medications where such claims have not been established and are not described in the drug labeling and continue to warn patients and health care professionals that they should not rely on these tests for treatment decisions.”
     
    “To be able to detect genetic variants and use them in determining an appropriate course of care is one way in which we encourage research and innovation. We have so much more to learn about the use of these tests for specific medications, what the results mean, and how we can apply the information to improve a patient’s health,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “While we are committed to supporting innovation in this area, we will also be vigilant in protecting against the potential risks and are therefore issuing this warning letter to help protect patients and providers from acting on data that has not been demonstrated to promote the safe and effective use of drugs.”
     
    The use of some drugs can be informed by pharmacogenetic testing. When the agency has reviewed scientific evidence demonstrating a relationship between the drug’s effects and genetic variants and determined the information is sufficient to be included in the drug labeling, information about how to use the genetic test results to manage medication treatment is described in the labeling for the specific drug to assure safe use of the drug.
     
    The FDA issued a warning letter to Inova for marketing pharmacogenetic tests that have not been reviewed by the FDA and that claim to predict patients’ clinical responses to specifically named drugs, including antidepressants, opioids, cancer treatments, anesthesia, and diabetes medications. The FDA has not reviewed and is unaware of any data establishing that Inova’s tests can help patients or health care providers use the listed drugs more safely or effectively. The warning letter requests that Inova respond, within 15 working days from the date the warning letter was received, with details of how the violations noted in the warning letter will be corrected. Any violations not corrected could lead to enforcement action such as seizure, injunction or civil money penalties.
     
    Tests that make claims that have not been evaluated by the FDA may influence health care providers and patients to inappropriately select or change drug treatment based on the results from genetic tests. Acting on these results could lead to potentially serious health consequences for patients. For example, patients may change the dose of their medication for a particular condition or disease based on the results of such a genetic test, which may lead to an incorrect treatment or worsening illness.
     
    Last year, the agency issued a safety communication warning consumers and health care professionals about pharmacogenetic tests being marketed directly to consumers or offered through health care providers that claim to predict how a patient will respond to specific medications.
     
    Following issuance of the safety communication, the FDA reached out to several firms marketing pharmacogenetic tests with claims to predict how a person will respond to specific medications in cases where the relationship between genetic (DNA) variations and the medication's effects has not been established. Most firms addressed the FDA’s concerns by removing specific medication names from their labeling, including promotional material and patient test reports.
     
    These actions, including the warning letter, reflect the agency’s commitment to advancing policies that enhance the FDA’s oversight of device safety. As part of the Medical Device Safety Action Plan, the FDA has warned the public when safety issues are identified, such as with thermography devices.
     
    Health care professionals and consumers should report any adverse events related to these and other genetic tests to the FDA’s MedWatch Adverse Event Reporting program. To file a report, use the MedWatch Online Voluntary Reporting Form. The completed form can be submitted online or via fax to 1-800-FDA-0178. The FDA monitors these reports and takes appropriate action necessary to ensure the safety of medical products in the marketplace.
    Related Searches
    • cancer
    • genetics
    • diabetes
    • research
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Bright Future Ahead for Renal Denervation Bright Future Ahead for Renal Denervation
    FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients
    Baxter Begins Collaboration with Amazon Web Services Baxter Begins Collaboration with Amazon Web Services
    Phillips-Medisize Unveils Aria Smart Autoinjector Platform Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    BioFourmis BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    BD Acquires Velano Vascular BD Acquires Velano Vascular
    DataRobot Launches AI for Health Incubator DataRobot Launches AI for Health Incubator
    Heartbeat Health Raises $20 Million Series B Funding Heartbeat Health Raises $20 Million Series B Funding
    Expanded FDA Approval for Medtronic Expanded FDA Approval for Medtronic's Arctic Front Cryoablation Catheter
    FDA Approves Medtronic FDA Approves Medtronic's SenSight Directional Lead System for DBS
    Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure
    LivaNova, Verily Begin Difficult-to-Treat Depression Study LivaNova, Verily Begin Difficult-to-Treat Depression Study
    Berlin Heals Berlin Heals' C-MIC Heart Failure Implant Achieves Breakthrough Device Status
    Top Five Healthcare Trends and Predictions for 2021 Top Five Healthcare Trends and Predictions for 2021
    Abbott Releases NeuroSphere Virtual Clinic for Remote Neuromodulation Care Abbott Releases NeuroSphere Virtual Clinic for Remote Neuromodulation Care

    Related Breaking News

    • Bright Future Ahead for Renal Denervation

      Bright Future Ahead for Renal Denervation

      No devices yet approved in the United States for the high blood pressure treatment.
      GlobalData 09.02.21

    • Neurological
      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      Expanded depression indication further demonstrates company’s leadership position.
      GlobeNewswire 08.19.21

    • Digital Health
      Baxter Begins Collaboration with Amazon Web Services

      Baxter Begins Collaboration with Amazon Web Services

      Advancing strategic priorities in digital health, customer experience, and technology modernization.
      Baxter 08.03.21


    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Small and easy-to-use injection device is designed to support medication management.
      Phillips-Medisize 08.02.21

    • Cardiovascular | Digital Health
      BioFourmis

      BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status

      Augments guideline-directed use of heart failure medications.
      PR Newswire 07.30.21

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • The Future Of Biomedical Engineering Advancements
    • A New Approach To Post-Market Surveillance
    Breaking News
    • MPO's Most-Read Stories This Week—Feb. 4
    • MO SCI Acquires Assets of 3M’s Advanced Materials Business
    • Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Feb. 4
    MO SCI Acquires Assets of 3M’s Advanced Materials Business
    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly 4Q Revenues Down 9% to $7.3B
    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica Introduces Glow Baby Skincare Line
    Kohl’s Names Tom Kingsbury as Chief Executive Officer
    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Happi

    Latest Breaking News From Happi

    Grant Industries Names Mehran Ghadim Sales Manager, Canada
    Bio-Oil Celebrates Body Confidence Through Body Positivity Month Campaign
    Net Sales for Clorox Increase 1% for Q2 2023
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Pigments, Inkjet Ink Market Reports Top This Week’s Stories
    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    MM Packaging adds first Nilpeter press for Dublin site
    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Feb. 4
    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: CES 2023, ams OSRAM and Celanese Top This Week’s Stories
    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login